Valproate (valproic acid; divalproex sodium, a compound containing sodium valproate and valproic acid) controls absence, myoclonic, and tonic-clonic seizures in generalized, idiopathic, and symptomatic epilepsy. It is most useful in typical absence seizures.

Latest news from VPA lab. Feb 2025 - New bilateral Tübitak Project by Prof. Berrin Yanıkoğlu on Reliable and Explainable AI Approaches for Medical Image Understanding, a collaboration with Dr. Fadoua Drira of the University of Sfax, Tunisia. Contact Prof. Yanıkoğlu for details.

Mar 19, 2024 · Valproic acid (VPA) ia as a highly prevalent medication with multifaceted therapeutic applications in various neurological and psychiatric disorders. The therapeutic uses of VPA include epilepsy treatment across different seizure types, bipolar disorder management, and migraine prophylaxis.

Valproic Acid - Valproic acid is used as an anticonvulsant to treat certain types of seizures, to prevent migraine headaches and to treat various psychiatric illnesses such as bipolar disorder and aggression.

Valproate (valproic acid; divalproex sodium, a compound containing sodium valproate and valproic acid) controls absence, myoclonic, and tonic-clonic seizures in generalized, idiopathic, and symptomatic epilepsy. It is most useful in typical absence seizures.

Feb 28, 2025 · Since valproic acid is highly bound, drugs that compete for protein binding sites can increase the amount of free valproic acid (biologically active protein); these include dicumarol, high dose salicylates, and phenylbutazone. If toxicity is suspected, a free valproic acid level should be obtained.

To determine the optimal safety range of free VPA concentration in adult patients. This prospective cohort study enrolled adult patients undergoing VPA therapy with TDM. Patient characteristics, VPA use, and adverse effects (thrombocytopenia, hyperammonemia, and hepatotoxicity) were recorded.

Free valproic acid may be important to monitor in patients with altered or unpredictable protein binding capacity because valproic acid exhibits variable, dose-dependent protein binding. Valproic acid is also subject to drug-drug interactions due to displacement of protein binding.

Valproic acid (valproate, Depakote, or Depakene) is an effective medication for absence seizures, generalized tonic-clonic seizures, and partial seizures, when administered alone or in conjunction with other antiepileptic agents. The valproic acid that circulates in blood is 85% to 90% protein-bound under normal circumstances.

The Valproic Acid Test is an essential diagnostic tool for patients undergoing treatment with valproic acid. By regularly monitoring blood levels of the drug, healthcare providers can ensure that patients receive the most effective dose while minimizing the risk of side effects.